Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bavarian Nordic A/S

BAVA.CO ✓ COMPLIANT ☆ Track — members

Nasdaq Copenhagen · Healthcare · Pharmaceuticals ·

Denmark Mid Cap Analyst: STRONG BUY

Last Close

$28.78

▲ +1.70%

Market Cap $2.27B · Vol 186.60K

Key Metrics

P/E Ratio

13.06

FWD: 21.42

Market Cap

$2.27B

Mid Cap

Div Yield

0.00%

Annual dividend

EPS Growth

-47.62%

YoY

RSI (14)

71.32

Momentum

Beta

0.44

vs Market

52W High

$37.89

25.14% below

52W Low

$26.52

9.86% above

Volume

186.60K

Avg 159.71K

P/B

1.16

Price-to-book

ROE

11.33%

Return on equity

Free Float

99.99%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bavarian Nordic A/S (BAVA.CO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BAVA.CO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.39%

+2.20%

-1.27%

-3.18%

YTD

-2.59%

-22.05%

+27.15%

-30.06%

Financials & Valuation

TTM · Annual

Total Revenue	$981.95M
Net Income	$216.30M
Revenue Growth (YoY)	-21.61%
Gross Margin	48.22%
Operating Margin	28.05%
Net Profit Margin	22.29%
ROE	11.33%
ROA · ROIC	12.27% · 11.25%

P/E Ratio	13.06
Forward P/E (FY1)	21.42
PEG Ratio	0.28
P/S	2.41
P/B	1.16
P/FCF	10.93
EPS Growth	-47.62%
Outstanding Shares	79.24M

Technical Indicators

50-Day SMA	$28.02
200-Day SMA	$29.55
RSI (14)	71.32
Beta	0.44
52-Week High	$37.89
52-Week Low	$26.52

Volume Today	186.60K
Avg Daily Volume (30D)	159.71K
Relative Volume	1.17x
Volatility (10D)	18.82
Volatility (30D)	19.14
Free Float	99.99%

Analyst Consensus

STRONG BUY

Current Price $28.78

Mean Target $39.25

52W Low$26.52 52W High$37.89

Current

Target

$26.52 $37.89

Current Analyst target

+36.40% upside potential · 3 analysts

Identifiers

ExchangeNasdaq Copenhagen

FIGIBBG001SD3068

ISINDK0015998017

CountryDenmark

Sub-IndustryPharmaceuticals (NEC)

Earnings DateAug 21, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.